David M. Berman - Feb 16, 2024 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Role
HEAD OF R&D
Signature
/s/ Lily Hepworth, Attorney-in-Fact
Stock symbol
IMCR
Transactions as of
Feb 16, 2024
Transactions value $
$0
Form type
4
Date filed
2/21/2024, 04:15 PM
Previous filing
Jan 2, 2024
Next filing
Feb 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMCR Employee Share Option (Right to Buy) Award $0 +111K $0.00 111K Feb 16, 2024 Ordinary Shares 111K $70.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.